Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Gonzalez Rodriguez

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
The Journal of Clinical Endocrinology and Metabolism|October 13, 2016
Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: 9 Clinical Cases ReportOlivier Lamy, Elena Gonzalez-Rodriguez, Delphine Stoll, et al.
Journal of Bone Oncology|August 4, 2020
Commentary to "Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials" (Galvano et al. J Bone Oncol 2019; 18:100252)Elena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Revue Medicale Suisse|July 11, 2017
[Osteoporosis in menopausal women between 40 and 65 years old : an algorithm for the gynaecologist]Anna Surbone, Nicolas Vulliemoz, Elena Gonzalez-Rodriguez, et al.
Praxis|June 7, 2018
[Multiple Vertebral Fractures after Denosumab Discontinuation: How to Avoid Them?]Olivier Lamy, Elena Gonzalez Rodriguez, Delphine Stoll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2020
Increased Risk of Multiple Spontaneous Vertebral Fractures at Denosumab Discontinuation Must Be Taken Into AccountElena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Revue Medicale Suisse|April 18, 2019
[How to manage the rebound effect at denosumab discontinuation and avoid multiple vertebral fractures?]Elena Gonzalez Rodriguez, Olivier Lamy, Bérengère Aubry-Rozier, et al.
Breast Cancer Research and Treatment|October 11, 2019
Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitorsElena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Revue Medicale Suisse|May 3, 2023
[Does artificial intelligence have a role in osteoporosis management?]Colin Vendrami, Guillaume Gatineau, Enisa Shevroja, et al.
International Journal of Epidemiology|November 10, 2025
Cohort Profile Update: The OsteoLaus studyEnisa Shevroja, Colin Vendrami, Guillaume Gatineau, et al.
JBMR Plus|August 7, 2024
Standardization of body composition parameters between GE Lunar iDXA and Hologic Horizon A and their clinical impactColin Vendrami, Guillaume Gatineau, Elena Gonzalez Rodriguez, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Endocrinology and Metabolism|October 13, 2016
Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: 9 Clinical Cases ReportOlivier Lamy, Elena Gonzalez-Rodriguez, Delphine Stoll, et al.
Journal of Bone Oncology|August 4, 2020
Commentary to "Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials" (Galvano et al. J Bone Oncol 2019; 18:100252)Elena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Revue Medicale Suisse|July 11, 2017
[Osteoporosis in menopausal women between 40 and 65 years old : an algorithm for the gynaecologist]Anna Surbone, Nicolas Vulliemoz, Elena Gonzalez-Rodriguez, et al.
Praxis|June 7, 2018
[Multiple Vertebral Fractures after Denosumab Discontinuation: How to Avoid Them?]Olivier Lamy, Elena Gonzalez Rodriguez, Delphine Stoll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2020
Increased Risk of Multiple Spontaneous Vertebral Fractures at Denosumab Discontinuation Must Be Taken Into AccountElena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Revue Medicale Suisse|April 18, 2019
[How to manage the rebound effect at denosumab discontinuation and avoid multiple vertebral fractures?]Elena Gonzalez Rodriguez, Olivier Lamy, Bérengère Aubry-Rozier, et al.
Breast Cancer Research and Treatment|October 11, 2019
Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitorsElena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Revue Medicale Suisse|May 3, 2023
[Does artificial intelligence have a role in osteoporosis management?]Colin Vendrami, Guillaume Gatineau, Enisa Shevroja, et al.
International Journal of Epidemiology|November 10, 2025
Cohort Profile Update: The OsteoLaus studyEnisa Shevroja, Colin Vendrami, Guillaume Gatineau, et al.
JBMR Plus|August 7, 2024
Standardization of body composition parameters between GE Lunar iDXA and Hologic Horizon A and their clinical impactColin Vendrami, Guillaume Gatineau, Elena Gonzalez Rodriguez, et al.
Pageof 8